Impact of dose reductions on adjuvant abemaciclib efficacy for patients with high-risk early breast cancer: analyses from the monarchE study. Read more about Impact of dose reductions on adjuvant abemaciclib efficacy for patients with high-risk early breast cancer: analyses from the monarchE study.
Subgroup analyses from the phase 3 ASCENT study of sacituzumab govitecan in metastatic triple-negative breast cancer. Read more about Subgroup analyses from the phase 3 ASCENT study of sacituzumab govitecan in metastatic triple-negative breast cancer.
Circulating tumor cells in early lobular versus ductal breast cancer and their associations with prognosis. Read more about Circulating tumor cells in early lobular versus ductal breast cancer and their associations with prognosis.
Managing hyperglycemia and rash associated with alpelisib: expert consensus recommendations using the Delphi technique. Read more about Managing hyperglycemia and rash associated with alpelisib: expert consensus recommendations using the Delphi technique.
Tamoxifen or aromatase inhibitors with ovarian function suppression in pre-menopausal stage I-III lobular breast cancer. Read more about Tamoxifen or aromatase inhibitors with ovarian function suppression in pre-menopausal stage I-III lobular breast cancer.
Genomic analysis of advanced breast cancer tumors from talazoparib-treated gBRCA1/2mut carriers in the ABRAZO study. Read more about Genomic analysis of advanced breast cancer tumors from talazoparib-treated gBRCA1/2mut carriers in the ABRAZO study.
Clinical outcomes of de novo metastatic HER2-positive inflammatory breast cancer. Read more about Clinical outcomes of de novo metastatic HER2-positive inflammatory breast cancer.
High-dimensional immune cell profiling of cerebrospinal fluid from patients with metastatic breast cancer and leptomeningeal disease. Read more about High-dimensional immune cell profiling of cerebrospinal fluid from patients with metastatic breast cancer and leptomeningeal disease.
Biological insights and novel biomarker discovery through deep learning approaches in breast cancer histopathology. Read more about Biological insights and novel biomarker discovery through deep learning approaches in breast cancer histopathology.
Safety and efficacy of HSP90 inhibitor ganetespib for neoadjuvant treatment of stage II/III breast cancer. Read more about Safety and efficacy of HSP90 inhibitor ganetespib for neoadjuvant treatment of stage II/III breast cancer.
